These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11368001)

  • 21. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
    Kumar A; Cannon CP
    J Interv Cardiol; 2007 Dec; 20(6):447-57. PubMed ID: 18042049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 23. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic implictions of the lack of a lipid-lowering strategy].
    Baessler A; Fischer M; Hubauer U; Stark K; Hengstenberg W; Wiedmann S; Neureuther K; Holmer S; Mayer B; Schunkert H; Hengstenberg C
    MMW Fortschr Med; 2006 Nov; 148(44):38. PubMed ID: 17619439
    [No Abstract]   [Full Text] [Related]  

  • 25. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.
    Am J Cardiol; 1995 Sep; 76(7):474-9. PubMed ID: 7653447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
    Nissen S
    MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143
    [No Abstract]   [Full Text] [Related]  

  • 27. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
    Wiviott SD; Cannon CP; Morrow DA; Ray KK; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1411-6. PubMed ID: 16226163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of dyslipoproteinemia in chronic renal failure].
    Krane V; Wanner C
    MMW Fortschr Med; 2006 Apr; 148(14):34-7. PubMed ID: 16669278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute coronary syndrome. Statins in the early phase save lives].
    MMW Fortschr Med; 2001 Feb; 143(6):58. PubMed ID: 11247373
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Med; 2005 Dec; 118 Suppl 12A():22-7. PubMed ID: 16356804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering.
    Meredith IT; Plunkett JC; Worthley SG; Hope SA; Cameron JD
    Coron Artery Dis; 2005 Nov; 16(7):415-22. PubMed ID: 16205449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid levels after acute coronary syndromes.
    Pitt B; Loscalzo J; Ycas J; Raichlen JS
    J Am Coll Cardiol; 2008 Apr; 51(15):1440-5. PubMed ID: 18402897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical markers and the era of troponin.
    Christenson RH
    Md Med; 2001; Suppl():98-103. PubMed ID: 11434072
    [No Abstract]   [Full Text] [Related]  

  • 36. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute coronary syndromes with ST-segment elevation: fibrinolytic therapy].
    Cuccia C
    Ital Heart J; 2003 Dec; 4 Suppl 8():9S-15S. PubMed ID: 15005523
    [No Abstract]   [Full Text] [Related]  

  • 38. Variations in lipoprotein levels after myocardial infarction and unstable angina: the LATIN trial.
    Fresco C; Maggioni AP; Signorini S; Merlini PA; Mocarelli P; Fabbri G; Lucci D; Tubaro M; Gattone M; Schweiger C;
    Ital Heart J; 2002 Oct; 3(10):587-92. PubMed ID: 12478816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?
    Ray KK; Cannon CP
    Am J Cardiol; 2005 Sep; 96(5A):54F-60F. PubMed ID: 16126024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.